New Treatment Shows Promise in Lymphoma – Curetoday.com
Curetoday.com |
New Treatment Shows Promise in Lymphoma
Curetoday.com Researcher found that CD30-specific chimeric antigen receptor (CAR) T cells are a safe and durable treatment option to induce durable complete repsonses in patients who have Hodgkin lymphoma and anaplastic large cell lymphoma (ALCL), according to … |
